Therapeutics

Funding Opportunity: Detection of HIV for Self-Testing (R61/R33)

August 30, 2017

Announcement (FOA) Number PAR-17-471 

The purpose of this Funding Opportunity Announcement is to support bi-phasic developmental, discovery-driven, or hypothesis-driven research focused on innovative strategies to detect HIV either within the first two weeks of infection or to monitor viral rebound after stopping or developing resistance to antiretroviral therapy. Applications should propose simple dignostic tools that would be feasible for a self-testing platform to allow untrainded individuals to detect HIV. Interdisciplinary collaborations that...

Read more about Funding Opportunity: Detection of HIV for Self-Testing (R61/R33)
Forsyth

Postdoctoral Research Fellow Position Available at the Forsyth Institute, Cambridge, MA

August 10, 2017

A position for a postdoctoral research fellow is immediately available at the Forsyth Institute in Cambridge, Massachusetts             

We are very excited to embark on a NIH-sponsored project to develop a novel oral vaccine against HIV/AIDS. A postdoctoral fellow with a strong background in Immunology is sought for the careful planning and implementation of research projects involving assessments of mucosal/cellular immune responses to our novel HIV vaccine.

Please send submissions via...

Read more about Postdoctoral Research Fellow Position Available at the Forsyth Institute, Cambridge, MA
Scott Dryden-Peterson

Botswana’s cautionary tale of the co-epidemic of HIV and cervical cancer

October 13, 2016

HIV infection increases mortality in African women with cervical cancer

“Botswana was the first country in Africa to provide comprehensive HIV treatment to its citizens and has one of the most effective antiretroviral treatment programs globally,” Scott Dryden-Peterson, MD, instructor of medicine at Harvard Medical School and associate physician at Brigham and Women’s Hospital, told HemOnc Today. “As such, trends in Botswana are indicative of what will happen in other heavily HIV affected countries that also now have good access...

Read more about Botswana’s cautionary tale of the co-epidemic of HIV and cervical cancer